Single Gene Mutation Causes Milder Form of Rare Muscle Disease
Researchers identified a new genetic variant in the DAG1 gene that triggers a mild-to-moderate form of limb-girdle muscular dystrophy, challenging previous assumptions that only defective copies cause disease. The finding could reshape how clinicians diagnose and treat this rare condition, and may open new therapeutic approaches targeting protein function rather than gene replacement.
Originaltitel: Autosomal Dominant Missense <em>DAG1</em> Variant Linked to Mild–Moderate LGMD R16
<p>Limb-girdle muscular dystrophies (LGMDs) are disorders with an important clinical heterogeneity, usually involving proximal limb muscles. One subtype, LGMD R16 (LGMD 2P), is an autosomal recessive condition caused by pathogenic variants in DAG1, with clinical presentations ranging from mild to extremely severe forms. DAG1 is responsible for producing dystroglycan, an essential complex in the muscular protein network. Following translation, dystroglycan is cleaved into alpha-dystroglycan, which undergoes glycosylation and acts as a sarcolemmal receptor for extracellular proteins, and beta-dystroglycan, which connects to dystrophin. In recent years, heterozygous nonsense or frameshift DAG1 variants have been linked with asymptomatic hyperCKemia (increased serum creatine kinase levels) or mild muscular phenotypes characterized by fatigability and myalgia. Here, we describe a Romanian family comprising four affected individuals (one father and three sons) carrying the heterozygous missense DAG1 variant NM_004393.6:c.887G>A, NP_004384.5:p.(Gly296Asp) and showing a mild–moderate muscular phenotype similar to previous cases of DAG1 haploinsufficiency. Three of the affected individuals exhibit myopathic changes in muscle biopsies (increased fiber size variability, internalized nuclei, and regenerating fibers), while two demonstrate reduced alpha-dystroglycan glycosylation in muscle tissue. Atomic force microscopy findings in myoblasts from one patient showed a significantly lower stiffness compared to controls. These findings align with prior reports and further support the pathogenicity of this variant.</p>